Subscribe: Medscape Hematology-Oncology Headlines
http://www.medscape.com/cx/rssfeeds/2678.xml
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
breast cancer  breast  cancer survivors  cancer  exercise  medical news  medical  medscape medical  medscape  news  oncology  survivors 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Medscape Hematology-Oncology Headlines

Medscape Hematology-Oncology Headlines



Latest medical news, articles, and features from Medscape Hematology-Oncology



 



EU Says Yes to Mylotarg for AML, No to Adjuvant Sunitinib EU Says Yes to Mylotarg for AML, No to Adjuvant Sunitinib

Fri, 23 Feb 2018 14:25:42 EST

Gemtuzumab ozogamicin (Mylotarg) has been recommended for approval in Europe for use in acute myeloid leukemia, but adjuvant sunitinib after kidney cancer surgery was turned down.
International Approvals



Europe Says No to Neratinib for Breast CancerEurope Says No to Neratinib for Breast Cancer

Fri, 23 Feb 2018 13:51:56 EST

The European committee recommended against approval of neratinib (Nerlynx) for breast cancer, even though the drug has been approved in the United States.
International Approvals



'Moving the Needle' in Oncology Workforce Diversity'Moving the Needle' in Oncology Workforce Diversity

Thu, 22 Feb 2018 12:04:36 EST

Authors of a recent ASCO statement on diversity discuss their experiences and suggestions for improving inclusivity in the oncology workforce.
Medscape Oncology



Practice-Changing Data at 2018 GUCS 'Cannot Be Ignored'Practice-Changing Data at 2018 GUCS 'Cannot Be Ignored'

Thu, 22 Feb 2018 11:58:45 EST

A group of practice-changing trials presented at the 2018 Genitourinary Cancers Symposium highlights the growing importance of oncology subspecialty meetings, argues Dr David Graham.
Medscape Oncology



Adjuvant Chemo in Endometrial Cancer: Benefit Only for SomeAdjuvant Chemo in Endometrial Cancer: Benefit Only for Some

Thu, 22 Feb 2018 10:41:49 EST

PORTEC-3 results show that adjuvant chemotherapy improves failure-free survival, although not overall survival, in women with stage III high-risk endometrial cancer, but not in less advanced disease.
Medscape Medical News



Breast Cancer Survivors: Transition to PCP Leads to SavingsBreast Cancer Survivors: Transition to PCP Leads to Savings

Thu, 22 Feb 2018 10:30:20 EST

Transitioning breast cancer survivors from management by an oncologist to PCP was shown to use fewer health system costs and resources.
Medscape Medical News



Oncologist Awarded $13 Million in Gender Discrimination LawsuitOncologist Awarded $13 Million in Gender Discrimination Lawsuit

Thu, 22 Feb 2018 09:23:58 EST

After working at UCLA for 25 years and heading up the lymphoma program, Lauren Pinter-Brown, MD, claimed she experienced gender discrimination and then retaliation for complaining about it.
Medscape Medical News



Novel Tumor-Agnostic Agent: 80% RR, but Target Is RareNovel Tumor-Agnostic Agent: 80% RR, but Target Is Rare

Thu, 22 Feb 2018 06:33:22 EST

Oral larotrectinib is highly effective in up to 80% of metastatic solid tumors with a TRK fusion, regardless of patient age or tumor type, but these TRK fusions are rare.
Medscape Medical News



'Unrealistic Expectations' for Cancer Survivorship Care Plans'Unrealistic Expectations' for Cancer Survivorship Care Plans

Wed, 21 Feb 2018 06:02:12 EST

In the current literature, there is limited evidence of benefit from survivorship care plans. Researchers are calling for a shift in the focus of current research.
Medscape Medical News



Oncologist Critical in Motivating Cancer Survivors to ExerciseOncologist Critical in Motivating Cancer Survivors to Exercise

Tue, 20 Feb 2018 15:05:17 EST

Oncologists need to play a larger role in discussing exercise with cancer survivors, and home-based exercise interventions offer advantages, say Australian researchers.
Medscape Medical News



Suicide Among Cancer Survivors -- Highest Risk in HNCSuicide Among Cancer Survivors -- Highest Risk in HNC

Tue, 20 Feb 2018 06:33:23 EST

Compared to all other cancer types, with one exception, the risk for suicide is significantly higher among survivors of head and neck cancer (HNC).
Medscape Medical News



Exercise Improves Range of Motion After Lymph Node SurgeryExercise Improves Range of Motion After Lymph Node Surgery

Mon, 19 Feb 2018 08:08:22 EST

Exercise plus education improves arm mobility after lymph node dissection faster than does education alone, especially in the arm affected by the dissection.
Medscape Medical News



Exercise Benefits Cancer Patients Even 4 Years LaterExercise Benefits Cancer Patients Even 4 Years Later

Mon, 19 Feb 2018 05:16:45 EST

A long-term follow-up showed that an exercise program conducted during active treatment continues to confer benefits even 4 years later.
Medscape Medical News